Author

Yan Wang

Institutions: Open University of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital

Observed institutions: Open University of China, Capital Medical University, Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Ditan Hospital, Fu Wai Hospital

ORCID: 0000-0003-3070-9531

Observed ORCID: 0000-0003-3070-9531

OpenAlex ID: A5101387982

Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins

2024 · Yan Wang, Xin Qian, et al. · Cancer Medicine · 11

PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study

2024 · Zhi-Ming Wu, Jing Kan, et al. · American Heart Journal · 5

Exploring Diversity of Conopeptides and Revealing Novel Conoinsulins from Conus betulinus by Proteomic Analyses

2025 · Yan Wang, Yanbin He, et al. · Journal of Proteome Research · 4

Effects of dipeptidyl peptidase 4 inhibitors on the risk of acute respiratory failure in patients with type 2 diabetes mellitus: a meta-analysis of cardiovascular outcomes trials

2024 · Yan Wang, Caiyuan Yu, et al. · Endocrine Journal · 4

Works count: 4

Citation count: 24

H-index: 4

I10-index: 1